SCHEMBL15945925

SCHEMBL15945925

c1cc(-c2ccc3c(ccc4ccccc43)c2)c2c(c1)-c1cccc3c1c(cc1ccccc13)O2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.45
▸ HSD17B10 Q99714 5/20 0.45
▸ HPGD P15428 3/20 0.45
▸ HIF1A Q16665 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ TSHR P16473 2/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ CYP1A2 P05177 3/20 0.41
▸ ERBB2 P04626 1/20 0.41
▸ FYN P06241 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ AHR P35869 1/20 0.41
▸ CYP1B1 Q16678 1/20 0.37
▸ GPR84 Q9NQS5 2/20 0.36
▸ HPRT1 P00492 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ CYP2A6 P11509 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16883542 0.99 ALDH1A1 (0.44) ALDH1A1HSD17B10HPGDHIF1AMAPK1
SCHEMBL15600475 0.97 ALDH1A1 (0.43) ALDH1A1HSD17B10HPGDHIF1AMAPK1
SCHEMBL15600571 0.96 ALDH1A1 (0.42) ALDH1A1HSD17B10HPGDHIF1AMAPK1
SCHEMBL15600565 0.95 ALDH1A1 (0.43) ALDH1A1HSD17B10HPGDHIF1AMAPK1
SCHEMBL15600567 0.95 MAPK1 (0.43) ALDH1A1HSD17B10HPGDHIF1AMAPK1
SCHEMBL15945926 0.95 ALDH1A1 (0.43) ALDH1A1HSD17B10HPGDHIF1AMAPK1
SCHEMBL17167442 0.94 MAPK1 (0.45) ALDH1A1HSD17B10HPGDHIF1AMAPK1
SCHEMBL17167444 0.94 ALDH1A1 (0.40) ALDH1A1HSD17B10HPGDHIF1AMAPK1
SCHEMBL16883541 0.93 ALDH1A1 (0.42) ALDH1A1HSD17B10HPGDHIF1AMAPK1
SCHEMBL15600566 0.93 MAPK1 (0.44) ALDH1A1HSD17B10HPGDHIF1AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038152-B2 Organic light-emitting element CANON KABUSHIKI KAISHA (JP) 2018-07-31 — — US disclosed
US-10038152-B2 Organic light-emitting element CANON KABUSHIKI KAISHA (JP) 2018-07-31 — — US disclosed
US-9899613-B2 Organic light-emitting element CANON KABUSHIKI KAISHA (JP) 2018-02-20 — — US disclosed
US-9899613-B2 Organic light-emitting element CANON KABUSHIKI KAISHA (JP) 2018-02-20 — — US disclosed
EP-2939289-B1 ORGANIC LIGHT-EMITTING ELEMENT CANON KK (JP) 2017-07-26 — — EP disclosed
US-20150372244-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-12-24 — — US disclosed
US-20150372244-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-12-24 — — US disclosed
US-20150357586-A1 ORGANIC LIGHT-EMITTING ELEMENT SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-12-10 — — US disclosed
US-20150357586-A1 ORGANIC LIGHT-EMITTING ELEMENT SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-12-10 — — US disclosed
US-20150295188-A1 ORGANIC LIGHT-EMITTING ELEMENT SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-10-15 — — US disclosed
US-20150295188-A1 ORGANIC LIGHT-EMITTING ELEMENT SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-10-15 — — US disclosed
WO-2014123238-A1 ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2014-08-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038152-B2 Organic light-emitting element NFE2L2, EML4, LEF1 ALDH1A1 715/4885HSD17B10 3906/4885HPGD 3109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback